Oral biofilm surfaces are rich in negative charges. Traditional cationic small-molecule antimicrobial agents commonly suffer from application drawbacks such as staining and bitter taste. Polyhexamethylene biguanide (PHMB), leveraging the multi-site adsorption properties of its polymeric biguanide backbone, has emerged as the cationic antimicrobial polymer with the greatest industrial application potential since chlorhexidine. PHMB demonstrates outstanding application value and broad development prospects in the field of oral care.
I. Antimicrobial Mechanism
Polyhexamethylene biguanide achieves potent antimicrobial activity through a quadruple synergistic action:
- Electrostatic interactions: Rapidly anchors to phosphatidylserine on bacterial cell membranes, enabling targeted adsorption.
- Reduces bacterial membrane fluidity by 30%, forming transmembrane channels that cause massive leakage of intracellular K⁺ and ATP, disrupting cellular metabolic balance.
- Forms bridging interactions with anionic components in biofilm extracellular polymers (EPS), reducing biofilm thickness by 45% and destabilizing membrane structure.
- Sustained and stable antimicrobial activity. No reports of resistance mutations to date. Minimum inhibitory concentration (MIC) consistently maintained at 0.5–4 mg/L.
II. Formulation Technical Points
In oral care formulations, the effective concentration of PHMB should be controlled at 0.06–0.08%. Adjust the formulation pH to 5.5 using a sodium citrate buffer system to maintain ingredient stability. Content decline remains below 1.5% over 28 days. Formulations must exclude the anionic surfactant sodium lauryl sulfate (SLS). Alkyl Polysaccharide Glycoside (APG06) is the preferred surfactant. Adding 10% glycerin enhances moisturizing properties. Flavor masking is achieved through a microencapsulated blend of Dihydrochalcone (DC) and menthol. This reduces the product’s bitterness value by 35%, improving user experience.
III. Clinical Performance
Clinical trial data indicate that a single 30-second rinse with PHMB formulation reduces total bacterial colonies in saliva by 99.3%. Antimicrobial efficacy persists for 8 hours (maintaining a 2-log inhibition level). After 3 weeks of continuous use, subjects exhibited a 22% reduction in plaque index and a 26% decrease in gingival index. Soft plaque staining ΔE values were less than 1.5, significantly outperforming the chlorhexidine control group (ΔE=4.2). The formulation demonstrates outstanding efficacy in improving oral health metrics and reducing staining risk.
IV. Mucosal Adsorption and Sustained-Release Properties
PHMB exhibits electrostatic interaction with negatively charged oral mucosal surfaces via its positive charge, achieving adsorption levels of 1.8 μg/cm². Its desorption half-life is 6 hours, enabling prolonged retention.
When formulated with 0.15% Carbomer 974P to form a polyelectrolyte hydrogel, PHMB concentrations in saliva remained above MIC90 (90% inhibitory concentration) for 12 hours. PHMB with a molecular weight of 3 kDa demonstrated optimal adsorption efficiency, providing critical evidence for designing sustained-release formulations.
V. Safety Evaluation
PHMB exhibits excellent safety. Based on daily use of 20 mL of a 0.08% concentration formulation, the average daily intake is only 1.6 mg. This represents just 5% of the Acceptable Daily Intake (ADI=0.5 mg/kg) specified by the European Food Safety Authority (EFSA).
Both Ames test and micronucleus test results were negative, indicating no mutagenic risk. The irritation threshold exceeds 500 mg/L. It complies with the 0.1% upper usage limit stipulated in EU and Chinese cosmetic regulations. Its safety in use has been thoroughly validated.
VI. Competitive Performance Comparison
PHMB demonstrates significant advantages over traditional oral antibacterial agents. Compared to chlorhexidine, it reduces staining risk by 90% and lowers production costs by 30%. Compared to cetylpyridinium chloride (CPC), it broadens the antibacterial spectrum by 1.5 times. Its MIC value against Candida albicans is 4 times lower. It provides more comprehensive antimicrobial coverage. Compared to hydrogen peroxide, it lacks oxidative corrosion properties. Product packaging requires no additional light-shielding treatment, with more lenient storage conditions, offering outstanding overall application advantages.
VII. Conclusion
Future advancements through pH-sensitive carriers, electrospun patches, and deep eutectic solvent technology will extend PHMB’s applications to targeted caries treatment, post-surgical care, and extreme environments. This represents the core upgrade direction for antimicrobial agents in oral care.